Viking Therapeutics Announces Closing of Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters' Options to Purchase Additional Shares of Co
Go back to Viking Therapeutics Announces Closing of Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters' Options to Purchase Additional Shares of Co| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 26.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.38 | 52 Week High | $5.17 | |||
| Open | $26.38 | 52 Week Low | $0.94 | |||
| Day High | $26.38 | P/E | N/A | |||
| Day Low | $26.38 | EPS | $0.00 | |||
| Volume | 3,161 | |||||



